Abstract:Objective To determine the expression of Sema3A in serum and peripheral blood mononuclear cells ( PBMC) of patients with systemic lupus erythematosus ( SLE) , to analysis the correlation of Sema3A expression and SLE clinical manifestations and laboratory indexes , and to evaluate the diagnostic value of Sema3A in patients with SLE.Methods The concentration of serum Sema 3A was detected by enzyme-linked immuno sorbent assay (ELISA) in patients with SLE, healthy controls (HC) and diseases controls.In addition, the mRNA expression level of Sema3A was examined in PBMC by real-time polymerase chain reaction.The correlation of serum Sema3A level and clinical and laboratory features of SLE patients were analyzed.Unpaired t test, Kruskal-Wallis test, Mann-Whitney U test, χ2 test, Pearson and Spearman correlation analysis were used to statistical analysis by using SPSS 13.0.Results ( 1 ) Serum Sema3A concentration in patients with SLE was significantly lower than that in HC groups (P<0.01).(2) Consistent with the serum level, the Sema3A mRNA level in SLE was lower than that in HC (P=0.001). And the mRNA expression of Nrp-1 in SLE was also lower than that in HC ( P<0.01 ) .( 3 ) The serum Sema3A level in patients with SLE was positively correlated with haemoglobin ( HGB) ( r=0.271, P<0.013), platelet (PLT) (r=0.600, P<0.011), complement 3 (C3) (r=0.234, P=0.0027) and complement 4 (C4) (r=0.159, P=0.434) levels.Whereas, the expression of Sema3A was negatively correlated with SLE disease activity index (SLEDAI) (r=-0.286, P=0.036).(4) Area under curve illustrated by ROC curve was 0.876 (95%CI:0.846-0.906).The best cut-off value for the diagnosis of SLE was 6.31 μg/L, with the sensitivity of 80.6% and the specificity of 77.5%.The Youden index was 0.581.Above results indicated good validity of Sema 3A as a diagnostic marker for SLE.(5) The HGB, PLT, C3 and C4 levels in the group of Sema3A-positiveSLE patients (≤6.31 μg/L) were lower than that in negative group (>6.31 μg/L) , while CRP level and SLEDAI of positive group was higher than that in negative group(P<0.05).In addition, the positive rate of antinuclear antibodies (P=0.046) and anticardiolipin antibody (P=0.018) in the Sema3A-negative group were also significantly higher than that of negative group.Conclusions Sema3A and Nrp-1 was both decreased in serum and PBMC of SLE patients, suggesting that the circulating expression of Sema 3A and Nrp-1 was seriously defected in SLE. Circulating Sema3A was significantly correlated with disease activity and blood damage in patients with SLE . The result of ROC curve showed that Sema 3A had the potential to be a new diagnostic biomarker in SLE .

Serum Level of Anti-Monomer C-reactive Protein Antibody in Systemic Lupus Erythematosus

Aberrant T Cell Subsets and Cytokines Expression Profile in Systemic Lupus Erythematosus.

[The Clinical Significance of Hematological Damage in Systemic Lupus Erythematosus and Related Antibodies].

Clinical significance of serum sICAM-1 and sE-selectin in patients with active rheumatoid arthritis

Levels of Soluble Interleukin-2 Receptor and Clinical Significance in Patients with Systemic Lupus Erythematosus

Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions.

CRP Serum Levels Are Associated with High Cardiometabolic Risk and Clinical Disease Activity in Systemic Lupus Erythematosus Patients

Expression and Clinical Significance of Semaphorin 3A in Serum and Mononuclear Cells in Patients with Systemic Lupus Erythematosus

The study of the association of anti-C1q antibody with disease activity and lupus nephritis in SLE patients

Serum Interleukin-2 Receptor Α As a Clinical Biomarker in Patients with Systemic Lupus Erythematosus

The Role of Anti-mCRP Autoantibodies in Lupus Nephritis.

Clinical significance of anti-cyclic citrullinated peptides antibodies in systemic lupus erythematosus patients with arthritis

Serum Levels of Chemokines in the Patients With Systemic Lupus Erythematosus

What can we learn from the presence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus?

Urinary Modified C-Reactive Protein is Closely Associated with Tubulointerstitial Lesions in Lupus Nephritis.

Brief report on the relation between complement C3a and anti dsDNA antibody in systemic lupus erythematosus

The Clinical Significance of Soluble Axl and Tyro3 Receptor Tyrosine Kinase in Systemic Lupus Erythematosus

[Increased Serum C-C Chemokine Ligand 19 Levels Correlated with B Cell Abnormalities in Systemic Lupus Erythematosus].

The Complex Role of C-Reactive Protein in Systemic Lupus Erythematosus

Serum Level of Leptin in Patients with Systemic Lupus Erythematosus:Correlated with Lupus Activity

Serum Levels and Renal Deposition of C1q Complement Component and Its Antibodies Reflect Disease Activity of Lupus Nephritis